|

Anti-Asbestos Crusader, Dr. Irving Selikoff

21123039_Selikoff

From the 1960’s to the early 90’s, Dr. Irving J. Selikoff was both renowned for his pioneering research on the dangers of asbestos, and reviled for allegedly making exaggerated claims against the asbestos industry. In their recent article, “Science is Not Sufficient: Irving J. Selikoff and the Asbestos Tragedy,” Jock McCulloch and Geoffrey Tweedale revisit Dr. Selikoff’s life, illustrating how his landmark research helped shed light on a public health tragedy.

McCulloch and Tweedale, both historians with a long-term interest in the asbestos industry, decided to spotlight the late asbestos researcher because, “Nothing of any value had been written about Dr. Selikoff, despite his importance in changing public attitudes in the U.S. toward asbestos,” according to Dr. McCulloch. Their article became possible in 2006, when Dr. McCulloch was granted access to Dr. Selikoff’s personal papers at Mount Sinai Hospital in New York.

“Having read his letters we were both impressed by his integrity, his willingness to work with people with whom he disagreed, and his dedication to science as an open-ended enterprise,” says Dr. McCulloch.

Dr. Selikoff first gained attention for his studies of asbestos factory workers in the 1960s, a time when asbestos use in the United States was reaching an all-time high. His research linked the mineral to an alarmingly high risk of serious lung damage (known as asbestosis), as well as lung cancermesothelioma, and other cancers. As the data mounted, Dr. Selikoff became known as one of the most prominent and outspoken researchers on asbestos-related health disorders.

Yet public opinion wasn’t always with him. Asbestos up to that time had been regarded as a highly useful mineral, its flame-retardant properties positioning it as a protector of human health. It was a component of everything from pipe insulation to car brakes, and the linchpin of a highly lucrative industry.

When Dr. Selikoff took on the asbestos industry and brought to light the health crises faced by its workers, he faced intense opposition not only from the industry itself, but also from the media. He was attacked for making exaggerated claims against asbestos. Rumors even began to circulate that he had faked his medical degree.

By the 1980s, however, Dr. Selikoff appeared vindicated as the tide of public opinion shifted against asbestos. Tens of thousands of sick asbestos workers brought claims against the industry, and many won. In the 1980s, a government-mandated clean-up program in the U.S. led to massive asbestos removal projects in schools and office buildings.

Yet today, asbestos use continues in America, Canada, and much of the developing world, and its threat to public health persists. Before he died, Dr. Selikoff worried that perhaps he hadn’t been forceful enough in his efforts. Instead of pushing for a full ban on asbestos, he had hoped that science would find new ways to treat mesothelioma and the other cancers asbestos produces. “He could have been more confrontational with the big industries in the U.S.,” says Dr. McCulloch. “Instead, he believed that facts and science would hold sway. They didn’t.”

Dr. McCulloch believes that government and industry leaders today have an obligation to continue Dr. Selikoff’s legacy by looking “at the science and the hard evidence” surrounding the dangers of asbestos and by ensuring that “men and women are protected in the workplace.”

Sources:

McCulloch J, Tweedale G. Science is not sufficient: Irving J. Selikoff and the asbestos tragedy. New Solutions, 2007;17:293-310.

Bartrip, P.W.J. Irving John Selikoff and the case of the missing medical degrees. Journal of the History of Medicine and Allied Sciences, 2003;58: 3-33.

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…